News
-
Drug Delivery to the Lungs (DDL) 24 will take place December 11-13 2013 in the recently expanded Edinburgh International Conference Centre (EICC), and organizers from the Aerosol Society say that they are eager to make… Read more . . .
-
Submit poster abstracts for RDD 2014 by January 10, 2014 http://www.rddonline.com/rdd/poster_reg.php?id=9. For complete details and instructions, see http://www.rddonline.com/rdd/rdd.php?id=9&sid=4&sub=272. Read more . . .
-
Florida-based Puget Technologies has announced that its subsidiary Cannabis Biotech has initiated a research project to develop an intranasal formulation of cannabinoids, saying that the “project is targeted towards those who desire the benefits of… Read more . . .
-
Aerosol component and filling specialist Coster has announced that it will develop and construct a 150 can/minute MDI filling line for Catalent Pharma Solutions’s Inhalation Center of Excellence in Research Triangle Park, NC. Catalent announced… Read more . . .
-
Boehringer Ingelheim has announced the approval of Striverdi Respimat olodaterol SMI for the treatment of COPD in the United Kingdom, Denmark and Iceland, noting that additional approvals in EU countries “will follow in due course.”… Read more . . .
-
Discovery Laboratories has submitted an investigational new drug (IND) application for its Aerosurf aerosolized KL4 surfactant for the treatment of respiratory distress syndrome (RDS) in premature infants, the company has announced. Assuming the FDA review… Read more . . .
-
Cystic Fibrosis Foundation Therapeutics (CFFT) has awarded Savara Pharmaceuticals $1.7 million for further development of AeroVanc inhaled vancomycin for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis patients. CFFT is a… Read more . . .
-
Insmed has announced that it anticipates discussions with the EMA by the end of 2013 regarding Arikace inhaled liposomal amikacin for the treatment of nontuberculous mycobacterial (NTM) lung disease and that it has already initiated… Read more . . .
-
Under a new joint venture, Harmony Asset will pay development costs for Dance Biopharm’s Adagio inhaled insulin in Asian countries, including Korea, India, Indonesia and Australia, Dance has announced. The agreement excludes Japan. Harmony will… Read more . . .
-
Inhalation testing automation specialist Astech Projects has announced the launch of a new website at www.astechprojects.com. The new site allows for easier access to information about the company’s business units, including drug delivery automation. The… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.